A series of substituted dihydropyrimidin-2(1 H )-thione derivatives ( 1–8 ) have been synthesized and docked against enzymes human topoisomerase II alpha (4FM9) and Helicobacter pylori urease (1E9Y) for binding mode validation.
No takes yet. Share an insight, caveat, or question.
Andleeb et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: